Why the study?
Does bendroflumethiazide reduce supine blood pressure in patients with essential hypertension persistent on nifedipine?
Does bendroflumethiazide reduce supine blood pressure in patients with essential hypertension persistent on nifedipine?
Adding bendroflumethiazide to nifedipine significantly reduces blood pressure in patients with persistent hypertension, challenging theoretic arguments that the combination is ineffective.
Answers are grounded in this paper and cite their sources.
Supports adding bendroflumethiazide to nifedipine for persistent hypertension; challenges theoretical arguments against combination efficacy.
It has been suggested that a diuretic added to a calcium antagonist may not reduce blood pressure further in patients with hypertension. Bendroflumethiazide 5 mg was given to 17 patients with essential hypertension who had persistent mild to moderate hypertension despite treatment with nifedipine slow-release tablets 20 mg bid. One group received bendroflumethiazide before (N = 8) and the other after placebo (N = 9) in a double-blind, randomized cross-over trial. Supine blood pressure following active bendroflumethiazide administration was significantly reduced in both groups compared with trial entry (166/105 to 150/96 mm Hg, P less than .01; 170/108 to 156/98 mm Hg, P less than .01). A reduction in serum potassium level and a rise in serum uric acid concentration were seen with combined treatment. We cannot substantiate theoretic arguments for the ineffectiveness of a bendroflumethiazide-nifedipine combination on blood pressure.
No takes yet. Share an insight, caveat, or question.
Zezulka et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: